Piper Sandler Just Hiked Humana Target to $254
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Learn the key wash sale rules disallowing crypto losses in 2026 and how to approach reporting and avoidance strategies.
22,404 articlesPiper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
Medicare Part B costs are climbing in 2026, pulling more from Social Security checks and narrowing the real value of ...
Energy stocks are staging a comeback in 2026 as crude oil recovers and demand improves. The IYE ETF leads gains, sign...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
Investors chasing steady monthly payouts in JEPQ face a trade-off: higher income amid lower long-run gains versus bro...
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Axon Enterprise jumped in premarket trading following a strong Q4 and a sharp rise in annual bookings, signaling dura...
As March 2026 unfolds, a wave of investing apps aimed at college students is reshaping how young people start buildin...
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
ARTY leads humanoid-robot ETFs in 2026, outpacing BOTT and ROBO as investors chase AI software momentum. This shift h...
Global CFO appointments cooled in Q1 2026 while retirements surged, spotlighting a shortage of battle-tested cfos and...
Small-cap value has accelerated ahead of growth in 2026, with three ETFs leading the pack by delivering a clear facto...